Delivery Order SPE2DB20D3103-SPE2DB23FM9Q3
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,579.36 Firm Fixed Price Delivery Order is for the supply of Brimonidine Tartrate 0.15% eye drops, with a completion date of February 12, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,774.84 delivery order contract is for the supply of brimonidine tartrate 0.15% eye drops, a medication used to treat glaucoma. The contract is a Firm Fixed Price (FFP) delivery order that is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,989.30 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide brimonidine tartrate 0.1% eye drops. This order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) the company holds with DLA Troop Support Medical, which serves as a primary vehicle for supplying a comprehensive range of pharmaceutical products and medical supplies to support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,745.53 firm fixed-price delivery order is for the supply of Brimonidine-Timolol 0.2%-0.5% eye drops in 10 mL bottles. The contract has an ultimate completion date of October 22, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $1,801.50 Firm Fixed Price Delivery Order is for the supply of Brimonidine Tartrate 0.15% eye drops, a pharmaceutical product used for the treatment of ocular conditions. The contract has a performance period through March 27, 2023 and does not include any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of Brimonidine Tartrate 0.15% eye drops, a medication used to treat increased eye pressure. The contract has a ceiling value of $5,574.52 and a period of performance through January 2, 2024. It is a firm-fixed-price contract, with no set-aside designation indicated....
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,008.76 and is for the procurement of BRIMONIDINE TARTRATE 0.15% DRP 5ML, a specialized eye drop medication. The contract has a firm fixed price pricing type and an ultimate completion date of May 14, 2024. This delivery order is part of a larger Indefinite Delivery...
- This federal contract award is for the delivery of Brimonidine Tartrate 0.15% eye drops in 15mL bottles to the Defense Logistics Agency (DLA). The $1,451.83 firm fixed price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021. The contract has an ultimate completion date of September 27, 2021 and is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 held by Amerisourcebergen's parent...
- This federal contract award, with an ID of SPE2DB20D1051|SPE2DB25FD6WQ, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,140.02, is for the delivery of brimonidine tartrate 0.1% eye drops in 5 ml containers. The contract is a Firm Fixed Price Delivery Order, with a completion date of January 31, 2025. Amerisourcebergen Drug Corp, the prime contractor, does not have any...
- The Defense Logistics Agency awarded a $3,193.50 firm fixed price delivery order to AmerisourceBergen Drug Corp for Brimonidine Tartrate 0.15% ophthalmic drops (10mL) on September 19, 2025, with an ultimate completion date of September 22, 2025. This non-set-aside competitive award was fulfilled by AmerisourceBergen's Corporate Office division, with performance to be completed at the vendor's Conshohocken, Pennsylvania location. The delivery order represents a child contract under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB23FM9Q3Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,883.20 Firm Fixed Price Delivery Order covers the supply of Brimonidine Tartrate 0.15% eye drops, a medication used to treat glaucoma. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.9k | 4/3/23 |